Current Treatment Options for Fuchs Endothelial Dystrophy

Current Treatment Options for Fuchs Endothelial Dystrophy

Jun, Albert S.; Cursiefen, Claus

Springer International Publishing AG

07/2018

255

Mole

Inglês

9783319827179

15 a 20 dias

551

Descrição não disponível.
Epidemiology and genetic basis of Fuchs Endothelial Corneal Dystrophy.- MicroRNAs in FED: New therapeutic option?.- Clinical phenotypes of Fuchs Endothelial Corneal Dystrophy (FECD), disease progression, differential diagnosis, and medical therapy.- Optical and anatomic changes in Fuchs Endothelial Dystrophy corneas.- Evolution of posterior lamellar keratoplasty: PK-DLEK-DSEK/DSAEK-DMEK-DMET.- DMEK Graft Preparation: eye bank perspective and risk factors for preparation failure.- Donor-tissue splitting and tissue storage for DALK and DMEK surgery.- DSAEK and UT-DSAEK in FED: Step-by-step approach.- DSAEK (not only) in Asian eyes: What glide to use? Optimized insertion techniques.- Intra- and postoperative complications and their management in DMEK.- DMEK: step-by-step surgical approach.- Complications of Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) surgery.- Revision for failed penetrating keratoplasty in FED.- Long-term clear graft survival and chronic endothelial cell loss following posterior lamellar keratoplasty.- Immune reactions and dry eye after posterior lamellar keratoplasty.- Tissue engineering of a healthy corneal endothelium for FECD patients.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Complication management;DALK;DMEK;DSAEK;Penetrating keratoplasty (PK)